BRINEURA — BIOMARIN PHARM, approved 2024-07-24 (BLA761052).
434 reports across the top reactions. These are spontaneously reported events from the FDA Adverse Event Reporting System — they reflect reporting volume, not incidence or frequency, and a report does not mean the drug caused the event.